BRIEF published on 09/21/2026 at 07:50, 1 month 15 days ago ALIKO Scientific Settles Dispute, US Subsidiary to Receive $2 Million Euronext Growth US Subsidiary Oncology Diagnostics Settlement ALIKO SCIENTIFIC
BRIEF published on 09/21/2026 at 07:50, 1 month 15 days ago ALIKO Scientific concludes a $2 million deal Dispute ALIKO SCIENTIFIC Transactional Agreement Oncological Diagnosis American Subsidiary
PRESS RELEASE published on 09/21/2026 at 07:45, 1 month 15 days ago Inside Information / Other news releases ALIKO Scientific settles dispute, US subsidiary to receive USD 2 million, related proceedings dismissed. ALIKO dedicated to oncology diagnostics US Subsidiary Oncology Diagnostics Settlement Dispute ALIKO SCIENTIFIC
BRIEF published on 09/15/2026 at 07:50, 1 month 21 days ago Aliko Scientific Expands in Brazil with Launch of Probantes ALIKO SCIENTIFIC FISH Probes Probantes Brazil Molecular Diagnostics Biodetecta Partnership
PRESS RELEASE published on 09/15/2026 at 07:45, 1 month 21 days ago Inside Information / Other news releases ALIKO Scientific launches Probantes in Brazil, establishing a new molecular diagnostic development and commercial platform for South America. Strategic agreement with Biodetecta enhances capabilities Brazil ALIKO SCIENTIFIC Probantes Molecular Diagnostic Biodetecta
BRIEF published on 09/07/2026 at 17:55, 1 month 29 days ago Aliko Scientific Launches U.S. Business Collaboration at ADLM 2026 U.S. Market ALIKO SCIENTIFIC ADLM 2026 Diagnostics Collaboration Partner International
PRESS RELEASE published on 09/07/2026 at 17:50, 1 month 29 days ago Inside Information / Other news releases Aliko Scientific partners with Partner International for U.S. business development at ADLM 2026, showing strong interest in oncology diagnostics technologies Oncology Diagnostics ALIKO SCIENTIFIC ADLM 2026 Partner International U.S. Business Development
BRIEF published on 08/24/2026 at 18:51, 2 months 13 days ago Aliko Scientific Updates Financial Position and Business Strategy Cash Flow Business Strategy Convertible Notes Financial Update Oncology Diagnostics
BRIEF published on 08/24/2026 at 18:47, 2 months 13 days ago Aliko Scientific: Financial Status and Outlook Convertible Bonds Financial Situation ALIKO SCIENTIFIC Outlook 2026 Oncological Diagnosis
PRESS RELEASE published on 08/24/2026 at 18:46, 2 months 13 days ago Inside Information: Other news releases ALIKO Scientific provides financial update post FY 2025 results publication, reaffirming business momentum. Details on auditors' reports, financial position, cash flow forecast, and convertible note financing Financial Update Convertible Note Financing Auditors' Reports ALIKO SCIENTIFIC FY 2025 Results
Published on 11/06/2026 at 22:15, 5 hours 50 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 15 hours 5 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 15 hours 35 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 15 hours 35 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 7 hours 50 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 8 hours 49 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 9 hours 5 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 9 hours 32 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 10 hours 5 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 10 hours 5 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 10 hours 10 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 10 hours 30 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
